A high-quality experimental dataset for predicting inhibition of the major drug-metabolizing Cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2D6, CYP3A4), released as part of the OpenADMET CYP Inhibition Blind Challenge.
Blog post: Announcing OpenADMET’s CYP inhibition blind challenge
Challenge Space: OpenADMET CYP Inhibition Blind Challenge
Challenge period: August 17, 2026 - November 3, 2026
Produced by: OpenADMET